About Regional Med. Ctr. at Memphis
"Regional One Health is a health care system providing accessible, efficient, quality care for individuals in the Mid-South. Its primary service area includes west Tennessee, east Arkansas and north Mississippi. Focusing on compassionate care and exceptional services, Regional One Health is anchored by the acute care hospital Regional Medical Center, which is home to highly respected Centers of Excellence including trauma, burn, neonatal intensive care and high-risk obstetrics. Also located at the main campus are Regional One Health Rehabilitation Hospital; Regional One Health Extended Care Hospital; Regional One Health Surgery Center; and an Outpatient Center. A second location, Regional One Health East Campus, houses specialty care physic"
Clinical Trials at Regional Med. Ctr. at Memphis
During the past decade, Regional Med. Ctr. at Memphis conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Regional Med. Ctr. at Memphis" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 10 trials, followed by "Glaxo Wellcome" with 4 trials
sponsored, "University of Tennessee" with 2 trials sponsored, "American Burn Association" with 1 trials sponsored and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Med. Ctr. at Memphis"
#1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Doctors Hospital-Joseph M Still Burn Center" with 1 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator and "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Regional Med. Ctr. at Memphis
According to Clinical.Site data, the most researched conditions in "Regional Med. Ctr. at Memphis" are
"HIV Infections" (15 trials), "Pregnancy" (7 trials), "Pneumonia, Pneumocystis Carinii" (2 trials), "Burns" (1 trials) and "Cerebrovascular Accident" (1 trials). Many other conditions were trialed in "Regional Med. Ctr. at Memphis" in a lesser frequency.
Clinical Trials Intervention Types at Regional Med. Ctr. at Memphis
Most popular intervention types in "Regional Med. Ctr. at Memphis" are "Drug" (15 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (5 trials), "Atovaquone" (3 trials), "Lamivudine" (3 trials), "Nevirapine" (2 trials) and "Abacavir sulfate, lamivudine, and zidovudine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Regional Med. Ctr. at Memphis
The vast majority of trials in "Regional Med. Ctr. at Memphis" are
12 trials for "All" genders and 7 trials for "Female" genders.
Clinical Trials Status at Regional Med. Ctr. at Memphis
Currently, there are NaN active trials in "Regional Med. Ctr. at Memphis".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Regional Med. Ctr. at Memphis,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Regional Med. Ctr. at Memphis, 4 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".